Get 30% off on all global market reports with code ONLINE30 – stay updated on tariff changes, macroeconomic trends, and more!
Cardiac Troponin Market Size Expansion: A Snapshot of Growth Between 2024 and 2029
In the past few years, the cardiac troponin market has seen swift growth. There will be an increase from $3.85 billion in 2024 to $4.24 billion in 2025, indicating a compound annual growth rate (CAGR) of 10.3%.
Factors attributing to the growth during the historical period includes the escalating incidence of cardiovascular illnesses, heightened awareness and earlier diagnosis of heart problems, growth of the healthcare system in emerging markets, a rise in the senior population, and the launch of high-sensitivity cardiac troponin assays.
Expectations are building for a significant upturn in the cardiac troponin market size over the upcoming years, with projections indicating a surge to $6.29 billion by 2029. This equates to a compound annual growth rate (CAGR) of 10.3%.
Numerous factors such as the increase in lifestyle-related cardiovascular diseases, the broadening of cardiac care units in healthcare facilities, the widespread adoption of at-home healthcare, the advancement of personalized medicine, and the need for more effective and affordable diagnostic alternatives are contributing to this forecasted growth. Leading trends for the forecast period consist of the utilization of machine learning algorithms for data interpretation in cardiac care, the broadening use of cardiac troponin beyond just acute coronary syndrome, ongoing progress in multiplex testing for simultaneous biomarker analysis, development of innovative biomarkers in conjunction with troponin, and the growth of personalized medicine.
Claim Your Free Sample Report:
http://www.thebusinessresearchcompany.com/sample….p;type=smp
Key Drivers Behind the Expansion of the Cardiac Troponin Market: Insights and Trends
The escalating occurrence of heart-related illnesses is anticipated to drive the expansion of the cardiac troponin market. Cardiovascular diseases such as coronary artery disease, heart failure, arrhythmias, and congenital heart defects are all encompassed under heart-related conditions and they all affect the structure and functionality of the heart.
The escalating occurrence of these conditions can be attributed to factors such as aging populations, inactive lifestyles, poor eating habits, and increasing incidence of obesity and hypertension.
The prominent role of cardiac troponin in diagnosing these conditions as a highly sensitive biomarker to detect damage of heart muscles, especially during heart attacks and other cardiac events, cannot be overlooked.
For instance, as per the Report on Registration of Births and Deaths 2023 by the Registry of Births and Deaths, Immigration and Checkpoints Authority, Singapore and Ministry Of Health, the total deaths due to ischemic heart diseases were numbered at 5,302, showing a minor increase from 5,290 in 2022. Hence, the escalating occurrence of heart-related conditions is projected to fuel the expansion of the cardiac troponin market.
Which Segments in the Cardiac Troponin Industry Are Seeing the Fastest Growth?
The cardiac troponinmarket covered in this report is segmented –
1) By Type: Troponin I; Troponin T
2) By Location Of Testing: Laboratory Setting; Point Of Care (Poc) Testing
3) By Application: Acute Coronary Syndrome; Myocardial Infraction; Congestive Heart Failure; Other Applications
4) By End User: Hospitals; Diagnostic Centers; Homecare Setting; Other End Users
Subsegments:
1) By Troponin I: Cardiac Troponin I (cTnI); Muscle Troponin I
2) By Troponin T: Cardiac Troponin T (cTnT); Skeletal Troponin T
Access the Full Report Today:
http://www.thebusinessresearchcompany.com/report/…ket-report
Which New Trends Will Create Growth Opportunities in the Cardiac Troponin Market?
Prominent businesses in the cardiac troponin market are prioritizing the development of innovative technologies like human serum-based quality controls to guarantee dependable and precise high-sensitivity troponin testing. These controls are used to check the efficacy of the assay by using human serum with known troponin levels.
For example, in May 2023, Bio-Rad Laboratories, Inc., a biotechnology research firm in the United States, launched Cardiac Advance. This is a four-level, multi-analyte quality control that’s specifically designed for high-sensitivity troponin testing.
These controls are liquid, derived from human serum, and are available in InteliQ 3-mL tubes, Liquichek 3-mL standard, and 2.5-mL compact vials. The controls contain 10 cardiac analytes, including troponin, CK-MB, BNP/proBNP, and myoglobin, and are compatible with testing platforms from Siemens and Roche.
They can be sourced from the U.S., Europe, and several markets in Asia.
Which Global Regions Are Powering Demand in the Cardiac Troponin Market?
North America was the largest region in the cardiac troponin market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period.
The regions covered in the cardiac troponin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get a Customized Version of the Report:
http://www.thebusinessresearchcompany.com/customi…p;type=smp
How Key Players Are Driving Growth in the Cardiac Troponin Market?
Major companies operating in the cardiac troponin market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA, Siemens Healthineers AG, Becton Dickinson and Company, Laboratory Corporation of America Holdings (Labcorp), Zoetis Inc., bioMérieux SA, Beckman Coulter Inc., QuidelOrtho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., Shenzhen Mindray Bio-Medical Electronics Co.
Ltd., Radiometer Medical ApS, Randox Laboratories Ltd., Fujirebio Diagnostics Inc., Meso Scale Diagnostics LLC., Singulex Inc., Diazyme Laboratories Inc., Response Biomedical Corporation, Eurolyser Diagnostica GmbH, LifeSign LLC
Access the Complete Report:
http://www.thebusinessresearchcompany.com/purchas…x?id=18986
How Our Market Research Reports Help Maximize ROI Across Industries:
* Identify High-Growth Opportunities: Pinpoint emerging trends, untapped segments, and regional hotspots that align with your strategic goals.
* Reduce Investment Risk: Make data-driven decisions with confidence by understanding market dynamics, key drivers, and competitive threats.
* Optimize Strategic Planning: Align your product development, marketing, and expansion plans with industry forecasts and customer behaviour insights.
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
News From
The Business Research Company …
Category: Industry Reports & Market Analysis Profile: The Business Research Company is a leading market research and consulting services provider. It offers over 9,500 market reports across 27 industries in 60+ geographies, providing detailed insights and forecasts. Its customised research solutions support companies in making critical decisions, while its continuous research service enhances organizational capabilities. The flagship Global Market Model database provides comprehensive market intelligence with 1,500,000 datasets covering 8,000+ mark …
This email address is being protected from spambots. You need JavaScript enabled to view it.
